J 2022

Expandable Lung Epithelium Differentiated from Human Embryonic Stem Cells

KOTASOVÁ, Hana, Michaela CAPANDOVÁ, Vendula PELKOVÁ, Jana DUMKOVÁ, Zuzana SUMBALOVÁ KOLEDOVÁ et. al.

Basic information

Original name

Expandable Lung Epithelium Differentiated from Human Embryonic Stem Cells

Authors

KOTASOVÁ, Hana (203 Czech Republic, belonging to the institution), Michaela CAPANDOVÁ (203 Czech Republic, belonging to the institution), Vendula PELKOVÁ (203 Czech Republic, belonging to the institution), Jana DUMKOVÁ (203 Czech Republic, belonging to the institution), Zuzana SUMBALOVÁ KOLEDOVÁ (703 Slovakia, belonging to the institution), Ján REMŠÍK (703 Slovakia, belonging to the institution), Karel SOUČEK (203 Czech Republic, belonging to the institution), Zuzana GARLÍKOVÁ (203 Czech Republic, belonging to the institution), Veronika SEDLÁKOVÁ (203 Czech Republic, belonging to the institution), Anas RABATA (760 Syrian Arab Republic, belonging to the institution), Petr VAŇHARA (203 Czech Republic, belonging to the institution), Lukáš MORÁŇ (203 Czech Republic, belonging to the institution), Lukáš PEČINKA (203 Czech Republic, belonging to the institution), Volodymyr POROKH (804 Ukraine, belonging to the institution), Martin KUČÍREK (203 Czech Republic, belonging to the institution), Libor STREIT (203 Czech Republic, belonging to the institution), Josef HAVEL (203 Czech Republic, belonging to the institution) and Aleš HAMPL (203 Czech Republic, guarantor, belonging to the institution)

Edition

TISSUE ENGINEERING AND REGENERATIVE MEDICINE, SEOUL, KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC, 2022, 1738-2696

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

20602 Medical laboratory technology ;

Country of publisher

Republic of Korea

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.600

RIV identification code

RIV/00216224:14110/22:00126034

Organization unit

Faculty of Medicine

UT WoS

000807342200001

Keywords in English

Lung; Epithelium; hESC; Differentiation; Foregut endoderm

Tags

International impact, Reviewed
Změněno: 14/3/2023 07:13, Mgr. Tereza Miškechová

Abstract

V originále

Background The progenitors to lung airway epithelium that are capable of long-term propagation may represent an attractive source of cells for cell-based therapies, disease modeling, toxicity testing, and others. Principally, there are two main options for obtaining lung epithelial progenitors: (i) direct isolation of endogenous progenitors from human lungs and (ii) in vitro differentiation from some other cell type. The prime candidates for the second approach are pluripotent stem cells, which may provide autologous and/or allogeneic cell resource in clinically relevant quality and quantity. Methods By exploiting the differentiation potential of human embryonic stem cells (hESC), here we derived expandable lung epithelium (ELEP) and established culture conditions for their long-term propagation (more than 6 months) in a monolayer culture without a need of 3D culture conditions and/or cell sorting steps, which minimizes potential variability of the outcome. Results These hESC-derived ELEP express NK2 Homeobox 1 (NKX2.1), a marker of early lung epithelial lineage, display properties of cells in early stages of surfactant production and are able to differentiate to cells exhibitting molecular and morphological characteristics of both respiratory epithelium of airway and alveolar regions. Conclusion Expandable lung epithelium thus offer a stable, convenient, easily scalable and high-yielding cell source for applications in biomedicine.

Links

MUNI/A/1390/2020, interní kód MU
Name: Analytická a fyzikální chemie ve výzkumu biologických, geologických a syntetických materiálů (Acronym: BIOGEOSYNT)
Investor: Masaryk University
MUNI/A/1398/2021, interní kód MU
Name: Zdroje pro tkáňové inženýrství 12 (Acronym: TissueEng 12)
Investor: Masaryk University
MUNI/A/1689/2020, interní kód MU
Name: Zdroje pro tkáňové inženýrství 11 (Acronym: TissueEng 11)
Investor: Masaryk University
NV16-31501A, research and development project
Name: Tkáňové inženýrství epitelů: Buňky a protokoly pro regenerativní medicínu
ROZV/28/LF23/2020, interní kód MU
Name: Objasněni vlivu ztráty TUSC3 na změnu fenotypových vlastnosti buněk ovariálního povrchového epitelu.
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects